Symbols

AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial

AZTA

Azenta·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Consensus Rating "Buy"

Ample Liquidity

Significant Net Income Decline

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About AZTA

Azenta, Inc.

A global provider of life sciences and advanced specialty chemicals

Industry

Medical service

Established Date

Listing Date

02/03/1995

Exchange

NASDAQ Stock Exchange

Full-time Employees

3,000

Fiscal Year Ends

09-30

Website

www.azenta.com

Security Type

Common stock

Office address

200 Summit Drive 6th Floor Burlington Massachusetts 01803

Business

Provides biological and chemical compound sample exploration and management solutions.

Introduction

Azenta, Inc., is a Delaware corporation established in 1978. The company is a leading global provider of biological and chemical compound sample exploration and management solutions for the life science industry. The company entered the life sciences market in 2011, leveraging the in-house precision automation and cryogenic capabilities they applied in the semiconductor manufacturing market at the time. Since then, the company has expanded its life science offerings through internal investments and a series of acquisitions. The company now supports clients from research and clinical development to commercialization with sample management, automated storage and genomic services expertise to help clients bring influential therapies to market faster. The company understands the importance of sample integrity and supports customers with a broad portfolio of products and services at every stage of the sample life cycle, including procurement and procurement, automated storage systems, genomic services and bulk sample consumables, informatics and data software, and sample repository solutions.

Company Financials

EPS

AZTA has released its 2026 Q3 earnings. EPS was reported at 0.16, versus the expected 0.11, beating expectations. The chart below visualizes how AZTA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

AZTA has released its 2026 Q3 earnings report, with revenue of 161.18M, reflecting a YoY change of 12.04%, and net profit of 2.46M, showing a YoY change of 105.12%. The Sankey diagram below clearly presents AZTA's revenue sources and cost distribution.